Search - tctmd.com

Displaying 61 - 80 of 190

Sort: Relevancy | Date

News Conference News ACC 2021

STEMI App Lowers Time to Treatment Across Regional Health System

Yael L. Maxwell

May 07, 2021

News Conference News ACC 2021

For Young Patients, Sex Gaps in MI Care Start in the Emergency Room

Caitlin E. Cox

May 06, 2021

News Conference News ACC 2021

Poorer Neighborhoods Pose Risks for Black Patients After Acute MI

L.A. McKeown

May 05, 2021

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Todd Neale

April 03, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

News Conference News ACC 2020

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Todd Neale

March 31, 2020

Presentation ACC 2020

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Presenter: Yangsoo Jang

March 30, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

Presentation ACC 2020

Mental Stress-Induced Myocardial Ischemia as a Marker for Adverse Cardiovascular Events After MI

Presenter: Zakaria Almuwaqqat

March 30, 2020

News Conference News ACC 2020

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Yael L. Maxwell

March 28, 2020

News Daily News ACC 2020

Mental Stress-Induced Ischemia Increases Risk of Poor Outcomes Post-MI

Michael O'Riordan

March 23, 2020

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Shelley Wood

April 05, 2019

News Conference News ACC 2019

Myocardial Injury Often Miscoded as Type 2 MI

L.A. McKeown

April 02, 2019

News Conference News ACC 2019

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Yael L. Maxwell

March 27, 2019

News Conference News ACC 2019

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

L.A. McKeown

March 27, 2019

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

News Conference News ACC 2019

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

Shelley Wood

March 19, 2019

Presentation ACC 2019

The SAfety and Efficacy of Femoral Access vs RadIal Access in STEMI: The SAFARI-STEMI Trial

Presenter: Michel R Le May

March 19, 2019

Advertisement

STEMI App Lowers Time to Treatment Across Regional Health System

For Young Patients, Sex Gaps in MI Care Start in the Emergency Room

Poorer Neighborhoods Pose Risks for Black Patients After Acute MI

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

TICO: Ticagrelor Monotherapy After 3 Months of DAPT Curbs Bleeding in Stented ACS Patients

Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After PCI: Randomized Evaluation Of Ticagrelor Monotherapy After 3- month Dual-antiplatelet Therapy In Acute Coronary Syndrome The TICO trial

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Mental Stress-Induced Myocardial Ischemia as a Marker for Adverse Cardiovascular Events After MI

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Mental Stress-Induced Ischemia Increases Risk of Poor Outcomes Post-MI

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

Myocardial Injury Often Miscoded as Type 2 MI

Ticagrelor Monotherapy Noninferior to DAPT After PCI in Adjudicated-Events Analysis: GLASSY

Sonothrombolysis for Acute STEMI? High-Frequency Microbubbles Show Promise in MRUSMI

Time and Money: PCI Public Reporting Requirements Take Their Toll

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel

The SAfety and Efficacy of Femoral Access vs RadIal Access in STEMI: The SAFARI-STEMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content